41 results
Page 2 of 3
8-K
EX-99.1
3b8quas
15 Aug 22
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2022 Results and Provides
4:19pm
424B5
zi4nc7na95ol0ud01996
25 Jul 22
Prospectus supplement for primary offering
4:26pm
S-3
wwz8vixqo2 0fkuz6cd
1 Jul 22
Shelf registration
8:46am
8-K
EX-99.1
p7qee0endnl
11 May 22
Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results and Provides Business Update
7:11am
8-K
EX-99.1
okmsmytca
17 Mar 22
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update
7:17am
10-K
if1hci5uremis34
16 Mar 22
Annual report
4:05pm
8-K
EX-99.1
oa7x 1hnag5k3s64v46v
16 Nov 21
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2021 Results and Provides Business Update
6:05am
8-K
EX-99.1
gvroukxwy ij
16 Aug 21
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2021 Results and Provides Business Update
4:11pm
10-Q
5f03vocl2 up1vgee
13 Aug 21
Quarterly report
4:06pm
424B4
upz 58io0h
28 Jun 21
Prospectus supplement with pricing info
6:02am
S-1/A
tk5 0a0woxhvl
11 Jun 21
IPO registration (amended)
6:02am
S-1
5jwp2
27 May 21
IPO registration
12:00am
S-1
EX-10.11
28f8t 2ryzr05ewh1tc
27 May 21
IPO registration
12:00am
DRSLTR
oi2iqa
10 May 21
Correspondence regarding draft registration statement
12:00am
DRS/A
hah57ymcg5wtnq
10 May 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.11
6qe3ymq 3v41dbt
10 May 21
Draft registration statement (amended)
12:00am
UPLOAD
fwetub 94aagsyq
30 Apr 21
Letter from SEC
12:00am